Vanda Pharmaceuticals Inc. - COM (VNDA)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
43.5M
Holdings value Q2 2024
$246M
Value change Q2 2024
-$19.6M
Grand Portfolio weight change Q2 2024
0%
Number of holders
146
Number of buys Q2 2024
82
Number of sells Q2 2024
-75
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 20.9K $98.5K +$45.8K $4.70 2
2024 Q2 43.5M $246M -$19.6M $5.65 149
2024 Q1 47.9M $197M -$11.9M $4.11 138
2023 Q4 50.7M $214M -$7.68M $4.22 154
2023 Q3 52.5M $227M -$23.8M $4.32 177
2023 Q2 56.2M $371M -$14.3M $6.59 186
2023 Q1 58.3M $396M +$17.2M $6.79 175
2022 Q4 55.5M $410M +$1.96M $7.39 184
2022 Q3 55.1M $544M -$11.3M $9.88 170
2022 Q2 56M $611M -$187K $10.90 165
2022 Q1 56.3M $637M +$17.4M $11.31 182
2021 Q4 54.3M $851M -$29.8M $15.69 197
2021 Q3 55.2M $947M +$4.38M $17.14 175
2021 Q2 54.8M $1.18B +$10.4M $21.51 177
2021 Q1 54.5M $820M -$4.49M $15.02 182
2020 Q4 55M $723M +$5.52M $13.14 171
2020 Q3 54.4M $526M -$8.61M $9.66 160
2020 Q2 55.1M $631M +$15.8M $11.44 160
2020 Q1 53.8M $557M +$130K $10.36 154
2019 Q4 52.8M $867M -$1.45M $16.41 170
2019 Q3 53M $703M -$21.6M $13.28 160
2019 Q2 54.3M $765M +$13.6M $14.09 158
2019 Q1 54.4M $1B +$5.34M $18.40 175
2018 Q4 53M $1.38B +$27.8M $26.13 184
2018 Q3 52.2M $1.2B +$80M $22.95 161
2018 Q2 49M $934M +$18.6M $19.05 136
2018 Q1 48.2M $812M +$129M $16.85 131
2017 Q4 40.9M $621M +$12M $15.20 127
2017 Q3 39.7M $710M +$16.5M $17.90 136
2017 Q2 38.8M $633M -$3.45M $16.30 133
2017 Q1 39.5M $553M +$43.7M $14.00 135
2016 Q4 40.6M $648M -$10.1M $15.95 141
2016 Q3 40.8M $678M +$66.6M $16.64 140
2016 Q2 37.2M $417M -$42.2M $11.19 115
2016 Q1 41.3M $345M -$12.8M $8.36 115
2015 Q4 42.6M $396M -$31.5M $9.31 115
2015 Q3 42.7M $482M +$466K $11.28 121
2015 Q2 42.4M $538M -$36.8M $12.69 111
2015 Q1 46.3M $431M -$27.6M $9.30 108
2014 Q4 47.7M $682M +$76.4M $14.32 110
2014 Q3 41.3M $428M +$24.1M $10.38 101
2014 Q2 38.5M $622M +$52.9M $16.18 111
2014 Q1 35.2M $571M +$57.3M $16.25 109